These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16162460)

  • 1. Clinical-grade myeloma Ag pre-loaded DC vaccines retain potency after cryopreservation.
    Szmania S; Yi Q; Cottler-Fox M; Rosen NA; Freeman J; Kordsmeier BJ; Moreno A; Shi J; Barlogie B; Tricot G; van Rhee F
    Cytotherapy; 2005; 7(4):374-84. PubMed ID: 16162460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
    Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
    Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.
    Kokhaei P; Adamson L; Palma M; Osterborg A; Pisa P; Choudhury A; Mellstedt H
    Cytotherapy; 2006; 8(4):318-26. PubMed ID: 16923607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a technology platform for large-scale clinical grade production of DC.
    Adamson L; Palmborg A; Svensson A; Lundqvist A; Hansson M; Kiessling R; Masucci G; Mellstedt H; Pisa P
    Cytotherapy; 2004; 6(4):363-71. PubMed ID: 16146889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
    Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
    J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired circulating myeloid DCs from myeloma patients.
    Do TH; Johnsen HE; Kjaersgaard E; Taaning E; Svane IM
    Cytotherapy; 2004; 6(3):196-203. PubMed ID: 15203976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma.
    Guardino AE; Rajapaksa R; Ong KH; Sheehan K; Levy R
    Cytotherapy; 2006; 8(3):277-89. PubMed ID: 16793736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF
    Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study on in vitro characterization of dendritic cells.
    Eichler H; Nguyen XD; Roelen D; Celluzzi CM; McKenna D; Pamphilon D; Blair A; Read EJ; Takahashi TA; Szczepiorkowski ZM;
    Cytotherapy; 2008; 10(1):21-9. PubMed ID: 18202971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
    Curti A; Isidori A; Ferri E; Terragna C; Neyroz P; Cellini C; Ratta M; Baccarani M; Lemoli RM
    Leuk Lymphoma; 2004 Jul; 45(7):1419-28. PubMed ID: 15359643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy.
    Hayden H; Friedl J; Dettke M; Sachet M; Hassler M; Dubsky P; Bachleitner-Hofmann T; Gnant M; Stift A
    J Immunother; 2009; 32(6):638-54. PubMed ID: 19483645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy.
    Elias M; van Zanten J; Hospers GA; Setroikromo A; de Jong MA; de Leij LF; Mulder NH
    J Clin Apher; 2005 Dec; 20(4):197-207. PubMed ID: 15892082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.
    van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Germeraad WT; Bos GM
    Cytotherapy; 2006; 8(1):36-46. PubMed ID: 16627343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
    Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE
    Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study on cryopreservation of immature dendritic cells derived from cord blood].
    Wang YT; Peng YZ; Tang J; Wang Q; Wang YQ; You B
    Zhonghua Shao Shang Za Zhi; 2006 Dec; 22(6):423-6. PubMed ID: 17438686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine].
    Zhang M; Yin XR; Luo YY; Lin X; Wang MC; He PC; Li J; Guo GL; Cai RH; Liu YL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):593-7. PubMed ID: 16532967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AML-loaded DC generate Th1-type cellular immune responses in vitro.
    Xing D; Decker WK; Li S; Robinson SN; Yang H; Segal H; O'Connor S; Yao X; Komanduri KV; McMannis JD; Jones RB; de Lima M; Champlin RE; Shpall EJ
    Cytotherapy; 2006; 8(2):95-104. PubMed ID: 16698683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.
    Eyrich M; Schreiber SC; Rachor J; Krauss J; Pauwels F; Hain J; Wölfl M; Lutz MB; de Vleeschouwer S; Schlegel PG; Van Gool SW
    Cytotherapy; 2014 Jul; 16(7):946-64. PubMed ID: 24831836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.